Key result
Successful catheter ablation may obviate ICD need in selected ACHD patients with reentrant monomorphic VT.
Answers are grounded in this paper and cite their sources.
May prompt arrhythmia surveillance in adults with congenital heart disease; leaves open need for larger confirmatory trials.
Patients with congenital heart disease associated with a higher risk for ventricular arrhythmias (VA) and sudden cardiac death (SCD) can be divided conceptually into those with discrete mechanisms for reentrant monomorphic ventricular tachycardia (VT) (Group A) and those with more diffuse substrates (Group B). Part I of this review addresses Group A lesions, which predominantly consist of tetralogy of Fallot and related variants. Well-defined anatomic isthmuses for reentrant monomorphic VT are interposed between surgical scars and the pulmonary or tricuspid annulus. The most commonly implicated critical isthmus for VT is the conal septum that divides subpulmonary from subaortic outlets. Programmed ventricular stimulation can be helpful in risk stratification. Although catheter ablation is not generally considered an alternative to the implantable cardioverter-defibrillator (ICD) for prevention of SCD, emerging data suggest that there is a subset of carefully selected patients who may not require ICDs after successful monomorphic VT ablation.
No takes yet. Share an insight, caveat, or question.
Bessière et al. (2023) conducted a review in Congenital heart disease with ventricular arrhythmias. In adults with congenital heart disease and discrete mechanisms for reentrant monomorphic ventricular tachycardia, successful catheter ablation may obviate the need for ICDs in carefully selected patients.
Synapse has enriched 10 related papers. Consider them for comparative context: